Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

"A one month supply of Lipozene can cost up to $90 as reported in this story. This article also pointed out that other companies sell similar supplementsfor a much lower cost. This story is clear and accurate in its overall message thatthere appear to be no weight-loss benefits from taking Lipozene. This story uses expert opinion to point out the severe diarrhea and gastrointestinal distress would be adverse effects of taking the very large doses of the glucomannan fiber in Lipozene that might help someone to lose weight. This story also noted that glucomannan is not FDA approvedas aweight-loss supplement. This authors of this story should be commended for their thorough research in medical literature and in consultation with independent experts to verify the lack of evidence supporting Lipozene's weight loss claims. The headline of this story ""Fiber-based Lipozene's weight-loss claims rest on thin evidence"" sums up the lack of credible evidence on whichLipozene bases its weight-loss claims. This story does a good job at pointing out that Lipozene's ""clinically proven"" ""fat-reducing power "" does not appear to be based on any data published in the medical literature. Perhaps this claim is based upon a small study reporting that individuals taking a fiber supplement similar to Lipozene on a very low calorie diet lost weight. Mathematically the amount of weight lost would be accounted for by diet alone. This story debunksLipozeneclaim that people can loseweight without dieting or exercisisngby citingcurrent medical opinion, and common sense. The story does point out that the Federal Trade Commission has taken legal action against the Obesity Research Institute for making false claims about its other gucomannan containing products. As a footnote,the Obesity Research Institutedoes not appear to conduct any research despite its ""lofty"" name. This story does not engage in disease mongering butclearly points out that themakers of Lipozene do. The parent company, Obesity Research Institute,capitalizeson thepublic's desire for a quick fix weight loss pill. This story took a well balanced approach to presenting both sides of the Lipozene story. Beneficial claims by the manufacturer were balanced with comments by two independent experts who expressed the opposite opinion. The story also tried unsuccessfully to verify claims that could not be otherwise verified with the manufacturer. The only significant omission ofthe story was notincluding basic information on weight-loss. Thisstory briefly mentions diet and exercise, but could more clearly state these are the proven ways to lose weight. Also, abrief sentence about gastric bypass surgeryin cases of severe obesity could have easily been included. There is no shortage of 'get thin quick products' being aggressively marketed in the media and widely available in drugstores trhoughout the country. Lipozene is no excpetion, as this story points out at the onset. This story makes it clear that weight-loss supplements including Lipozene are common place. We are confident the story did not rely on a news release."
Fiber-based Lipozene's weight-loss claims rest on thin evidence